Condition
Gastric Cancer (Including Stomach and Gastroesophageal Junction [GEJ]) clinical trials and research
Research outlook What's coming for Stomach cancer: the next 6 months to 5 yearsAs of November 12, 2026, Find a Trial lists 2 Gastric Cancer (Including Stomach and Gastroesophageal Junction [GEJ]) clinical trials that are recruiting, in China. By phase: Phase 3 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 1Country
All recruiting trials (2)
-
Neoadjuvant cadonilimab plus perioperative SOX for diffuse or mixed locally advanced stomach/GEJ cancer
This will test whether adding cadonilimab to perioperative SOX chemotherapy helps people with diffuse or mixed locally advanced stomach or gastroesophageal junction adenocarcinoma.
-
Comparing two treatment combinations for advanced gastric cancer
This study is testing if adding a new drug called apatinib to standard treatments can help people with advanced gastric cancer get better results and stay safe during treatment.
Related topics
Quick answers
How many Gastric Cancer (Including Stomach and Gastroesophageal Junction [GEJ]) clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in China. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.